News and Updates
NINDS Awards Reglagene $400,000 to Investigate a New Treatment for Glioblastoma Multiforme
Award enables application of its novel TERT gene-targeting technology to discover and develop a new therapy for GBM.
NCI Awards Reglagene $300,000 to Investigate a New Treatment for Prostate Cancer
Thank you, NCI! This award enables us to accelerate groundbreaking research targeting the TERT gene.
Startup Licenses University of Arizona Technology That Shortens Cancer Cell Life
The technology has been shown to be effective in shortening the lives of target cells, essentially inducing cancer cells to grow old and die.
Tucson Tech: Biotech Firm Is Advancing Method to "Turn Off" Cancer
Reglagene keeps moving forward with its technology to selectively turn genes on and off to combat cancer.
Seven Arizona Bio Startups Named Flinn Foundation Bio Entrepreneurship Program Winners
Proud to be one of seven Arizona bioscience startup firms selected to participate in the 2017 Flinn Foundation Bioscience Entrepreneurship Program.